Evaluation of 11 years of newborn screening for maple syrup urine disease in the Netherlands and a systematic review of the literature: Strategies for optimization.
Saved in:
| Title: | Evaluation of 11 years of newborn screening for maple syrup urine disease in the Netherlands and a systematic review of the literature: Strategies for optimization. |
|---|---|
| Authors: | Stroek K; Endocrinology Laboratory, Department of Clinical Chemistry Amsterdam Gastroenterology & Metabolism, Amsterdam UMC, University of Amsterdam Amsterdam The Netherlands., Boelen A; Endocrinology Laboratory, Department of Clinical Chemistry Amsterdam Gastroenterology & Metabolism, Amsterdam UMC, University of Amsterdam Amsterdam The Netherlands., Bouva MJ; Reference Laboratory Neonatal Screening, Center for Health protection National Institute for Public Health and the Environment Bilthoven The Netherlands., De Sain-van der Velden M; Section Metabolic Diagnostics, Department of Genetics University Medical Center Utrecht Utrecht The Netherlands., Schielen PCJI; Reference Laboratory Neonatal Screening, Center for Health protection National Institute for Public Health and the Environment Bilthoven The Netherlands., Maase R; Reference Laboratory Neonatal Screening, Center for Health protection National Institute for Public Health and the Environment Bilthoven The Netherlands., Engel H; Department of Clinical Chemistry Isala Hospital Zwolle The Netherlands., Jakobs B; Department of Clinical Chemistry Elisabeth-Tweesteden Hospital Tilburg The Netherlands., Kluijtmans LAJ; Translational Metabolic Laboratory, Department of Laboratory Medicine Radboud University Medical Center Nijmegen The Netherlands., Mulder MF; Department of Pediatrics, Division of Metabolic Disorders Amsterdam UMC, Vrije Universiteit Amsterdam Amsterdam The Netherlands., Rubio-Gozalbo ME; Department of Pediatrics and Clinical Genetics Maastricht University Medical Center Maastricht The Netherlands., van Spronsen FJ; Division of Metabolic Disorders, Beatrix Children's Hospital University Medical Center Groningen, University of Groningen Groningen The Netherlands., Visser G; Wilhelmina Children's Hospital University Medical Center Utrecht Utrecht The Netherlands., de Vries MC; Department of Pediatrics, Division of Metabolic Disorders Radboud University Medical Center Nijmegen The Netherlands., Williams M; Center for Lysosomal and Metabolic diseases, Department of Pediatrics Erasmus Medical Center Rotterdam The Netherlands., Heijboer AC; Endocrinology Laboratory, Department of Clinical Chemistry Amsterdam Gastroenterology & Metabolism, Amsterdam UMC, University of Amsterdam Amsterdam The Netherlands.; Endocrinology Laboratory, Department of Clinical Chemistry Amsterdam Gastroenterology & Metabolism, Amsterdam UMC, Vrije Universiteit Amsterdam Amsterdam The Netherlands., Kemper EA; Department of Clinical Chemistry IJsselland Hospital Capelle aan den IJssel The Netherlands., Bosch AM; Department of Pediatrics, Division of Metabolic Disorders Amsterdam UMC, University of Amsterdam Amsterdam The Netherlands. |
| Source: | JIMD reports [JIMD Rep] 2020 May 13; Vol. 54 (1), pp. 68-78. Date of Electronic Publication: 2020 May 13 (Print Publication: 2020). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 101568557 Publication Model: eCollection Cited Medium: Print ISSN: 2192-8304 (Print) Linking ISSN: 21928304 NLM ISO Abbreviation: JIMD Rep Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2192-8304 |
|---|---|
| DOI: | 10.1002/jmd2.12124 |
